secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardian Pharmacy Services, Inc. (GRDN)
CIK:        0001802255
Form:       8-K
Filed at:   2026-03-23T23:59:59+00:00
Accession:  0001193125-26-119772
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardian Pharmacy completes $31/share synthetic secondary; loses controlled company status
--------------------------------------------------------------------------------

- Company sold 1,020,000 new shares at $31 in public offering; used proceeds to buy 1,020,000 shares from holders, cancelling them; no net share change.
- Selling stockholders (Bindley Capital, Cardinal Equity, etc.) sold 5,880,000 shares; company received no proceeds from that portion.
- Selling stockholders no longer hold majority voting power; Guardian ceases to be a controlled company under NYSE rules as of March 20, 2026.
- Board established Nominating and Governance Committee with independent members Cosler, Lewis, Patchett effective March 20, 2026.
- Stock Purchase Agreements allow up to 1,833,344 share repurchases from holders; further public offerings possible until June 30, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802255/000119312526119772/0001193125-26-119772-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802255/000119312526119772/d171957d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-119772

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer